Loading...
XSHE300636
Market cap444mUSD
Jan 09, Last price  
7.76CNY
1D
-0.64%
1Q
-6.95%
IPO
30.01%
Name

Jiangxi Synergy Pharmaceutical Co Ltd

Chart & Performance

D1W1MN
XSHE:300636 chart
P/E
30.75
P/S
4.51
EPS
0.25
Div Yield, %
0.83%
Shrs. gr., 5y
4.02%
Rev. gr., 5y
22.01%
Revenues
722m
+0.31%
104,615,908141,555,599212,574,224274,814,061250,078,505296,716,027267,124,046413,058,080435,420,102592,126,648719,908,426722,138,705
Net income
106m
+5.28%
8,028,34616,883,60439,208,36562,879,09457,996,31565,457,72624,530,81648,309,30870,051,14981,119,813100,667,359105,983,257
CFO
164m
-16.45%
014,417,07264,501,99079,422,48260,445,42134,053,90474,932,539080,066,182131,338,816195,996,737163,748,533
Dividend
Jun 21, 20240.04 CNY/sh
Earnings
May 16, 2025

Profile

Jiangxi Synergy Pharmaceutical Co., Ltd. manufactures and sells APIs worldwide. It offers APIs, liquid crystal compounds, and intermediates. Jiangxi Synergy Pharmaceutical Co., Ltd. was founded in 2004 and is headquartered in Yichun, the People's Republic of China.
URL
http://www.jxsynergy.com/
IPO date
Mar 31, 2017
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
722,139
0.31%
719,908
21.58%
Cost of revenue
598,204
570,627
Unusual Expense (Income)
NOPBT
123,935
149,282
NOPBT Margin
17.16%
20.74%
Operating Taxes
6,517
5,482
Tax Rate
5.26%
3.67%
NOPAT
117,417
143,799
Net income
105,983
5.28%
100,667
24.10%
Dividends
(26,913)
Dividend yield
0.67%
Proceeds from repurchase of equity
(425)
BB yield
0.01%
Debt
Debt current
515,862
284,891
Long-term debt
254,076
332,151
Deferred revenue
4,018
4,028
Other long-term liabilities
Net debt
(231,658)
423,902
Cash flow
Cash from operating activities
163,749
195,997
CAPEX
(214,653)
Cash from investing activities
(706,206)
Cash from financing activities
955,259
68,571
FCF
(146,283)
(77,295)
Balance
Cash
512,753
141,964
Long term investments
488,842
51,176
Excess cash
965,489
157,145
Stockholders' equity
919,164
793,622
Invested Capital
2,079,204
1,779,593
ROIC
6.09%
8.58%
ROCE
4.08%
7.59%
EV
Common stock shares outstanding
380,392
346,183
Price
10.54
-28.83%
14.81
-15.72%
Market cap
4,009,328
-21.80%
5,126,972
-13.59%
EV
3,777,671
5,550,873
EBITDA
193,329
216,166
EV/EBITDA
19.54
25.68
Interest
10,647
7,699
Interest/NOPBT
8.59%
5.16%